116 related articles for article (PubMed ID: 25201504)
21. The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.
Hou X; Wei JC; Xu Y; Luo RZ; Fu JH; Zhang LJ; Lin P; Yang HX
Ann Surg Oncol; 2013 May; 20(5):1653-9. PubMed ID: 23247981
[TBL] [Abstract][Full Text] [Related]
22. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma.
Zhu Z; Yu W; Li H; Zhao K; Zhao W; Zhang Y; Sun M; Wei Q; Chen H; Xiang J; Fu X
Ann Surg Oncol; 2013 Sep; 20(9):3052-8. PubMed ID: 23686016
[TBL] [Abstract][Full Text] [Related]
23. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
24. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
25. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
28. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus].
Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566
[TBL] [Abstract][Full Text] [Related]
30. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
Wang Q; Yu S; Xiao Z; Liu X; Zhang W; Zhang X; He J; Sun K; Xu T; Feng Q; Zhou Z; Wang L; Yin W
Radiat Oncol; 2015 Jul; 10():142. PubMed ID: 26159510
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus.
Watanabe M; Ishimoto T; Baba Y; Nagai Y; Yoshida N; Yamanaka T; Baba H
Ann Surg Oncol; 2013 Nov; 20(12):3984-91. PubMed ID: 23797753
[TBL] [Abstract][Full Text] [Related]
32. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
[TBL] [Abstract][Full Text] [Related]
33. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Zhang M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
[TBL] [Abstract][Full Text] [Related]
34. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
[TBL] [Abstract][Full Text] [Related]
35. Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients.
Ma Q; Liu W; Jia R; Long H; Zhang L; Lin P; Zhao H; Ma G
Oncotarget; 2016 Jun; 7(25):38857-38863. PubMed ID: 27095577
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
Jiao XL; Chen D; Wang JG; Zhang KJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
[TBL] [Abstract][Full Text] [Related]
37. [Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].
FENG J; MAO T; CHEN WH; FANG WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):715-8. PubMed ID: 21948541
[TBL] [Abstract][Full Text] [Related]
38. Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations.
Peng J; Wang WP; Dong T; Cai J; Ni PZ; Chen LQ
Ann Thorac Surg; 2016 Jan; 101(1):280-6. PubMed ID: 26381757
[TBL] [Abstract][Full Text] [Related]
39. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
40. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Shigaki H; Iwagami S; Ishimoto T; Iwatsuki M; Baba H
Surgery; 2013 Feb; 153(2):234-41. PubMed ID: 22980434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]